"Our Child has Died - Hear 13/NTA/146 Approve Dr Jane Auckland District Health Board Observational our Story" TEST PROJECT - DO NOT 13/NTA/147 Approve Mr Nic Aagaard Observational USE A Study to Evaluate for the treatment of 13/NTA/148 Approve Prof Edward Gane Auckland Clinical Studies Limited Intervention Virally Suppressed, Chronic Hep B Subjects A study look at VS-6063 versus placebo in patients 13/NTA/149 Approve Dr. Richard Sullivan Auckland District Health Board Intervention with malignant pleural mesothelioma. Vemurafenib extension study in patients with Auckland District Health 13/NTA/15 Approve BRAFV600 Dr. Chris Wynne Intervention Taylor, CCST mutation−positive malignancies. Study of nasal delivery of 13/NTA/150 Approve Doctor Janine Pilcher Intervention warmed air Drospirenone 3 mg/ethinyloestradiol 0.02 mg Zenith Technology Corporation 13/NTA/151 Approve tablet bioequivalence study Dr Noelyn Hung Limited,Zenith Technology Intervention conducted under fasting Corporation Limited conditions Drospirenone 3 mg/ethinyloestradiol 0.03 mg Zenith Technology Corporation 13/NTA/152 Approve tablet bioequivalence study Dr Noelyn Hung Limited,Zenith Technology Intervention conducted under fasting Corporation Limited conditions Which school model for group A streptococci and Professor Diana 13/NTA/153 Approve Intervention acute rheumatic fever Lennon reduction? Improving patient screening Associate Professor 13/NTA/16 Approve for risk of malnutrition in the Mrs Tracey Eccles Stonehouse,Dr Russell Intervention hospital setting. (V-1.0) Walmsley Associate Professor 13/NTA/160 Approve ADVANCE Dr Andrew Hill Intervention Andrew Holden 13/NTA/161 Approve 1237.26 OTEMTO™ 2 Dr Andrew G Veale Carol Veale,Dr Andrew Veale Intervention
13/NTA/146 Approve "Our Child has Died - Hear our Story" Dr Jane Auckland District Health Board Observational 13/NTA/147 Approve TEST PROJECT - DO NOT USE Mr Nic Aagaard Observational 13/NTA/148 Approve A Study to Evaluate for the treatment of Virally Suppressed, Chronic Hep B Subjects Prof Edward Gane Auckland Clinical Studies Limited Intervention 13/NTA/149 Approve A study look at VS-6063 versus placebo in patients with malignant pleural mesothelioma. Dr. Richard Sullivan Auckland District Health Board Intervention 13/NTA/15 Approve Vemurafenib extension study in patients with BRAFV600 mutation−positive malignancies. Dr. Chris Wynne Auckland District Health Taylor, CCST Intervention 13/NTA/150 Approve Study of nasal delivery of warmed air Doctor Janine Pilcher Intervention 13/NTA/151 Approve Drospirenone 3 mg/ethinyloestradiol 0.02 mg tablet bioequivalence study conducted under fasting conditions Dr Noelyn Hung Zenith Technology Corporation Limited,Zenith Technology Corporation Limited Intervention 13/NTA/152 Approve Drospirenone 3 mg/ethinyloestradiol 0.03 mg tablet bioequivalence study conducted under fasting conditions Dr Noelyn Hung Zenith Technology Corporation Limited,Zenith Technology Corporation Limited Intervention 13/NTA/153 Approve Which school model for group A streptococci and acute rheumatic fever reduction? Professor Diana Lennon Intervention 13/NTA/16 Approve Improving patient screening for risk of malnutrition in the hospital setting. (V-1.0) Mrs Tracey Eccles Associate Professor Stonehouse,Dr Russell Walmsley Intervention 13/NTA/160 Approve ADVANCE Associate Professor Andrew Holden Dr Andrew Hill Intervention 13/NTA/161 Approve 1237.26 OTEMTO™ 2 Dr Andrew G Veale Carol Veale,Dr Andrew Veale Intervention
northern-a-ethics-committee-annual-report-2013.docx